DADC
FMI

D.A. Davidson & Co’s Foundation Medicine, Inc. FMI Stock Holding History

D.A. Davidson & Co’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-31,239
Closed -$567K – 2439
2016
Q1 		$567K Buy
31,239
+13,023
+71% +$210K 0.02% 497
2015
Q4 		$383K Buy
+18,216
New +$351K 0.01% 617

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.A. Davidson & Co's FMI Position: Q2 2016 in Review

D.A. Davidson & Co sold out of Foundation Medicine, Inc. (FMI) in Q2 2016, closing a stake of 31,239 shares — an estimated $567K sold.

D.A. Davidson & Co first reported a position in FMI in Q4 2015 and held it in 2 quarters. The position peaked at $567K in Q1 2016. 92 funds tracked by Wall St. Rank hold FMI as of Q2 2016.

  • D.A. Davidson & Co reported no remaining Foundation Medicine, Inc. position as of Q2 2016 after selling out during the quarter.
  • D.A. Davidson & Co sold 31,239 Foundation Medicine, Inc. shares in Q2 2016, an estimated $567K.
  • D.A. Davidson & Co first reported a position in Foundation Medicine, Inc. in Q4 2015 and held it in 2 quarters.
  • D.A. Davidson & Co's Foundation Medicine, Inc. position peaked at $567K in Q1 2016.
  • 92 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2016.

Based on D.A. Davidson & Co's 13F filing for Q2 2016, filed 15 Aug 2016.